Pharmaceutical Executive
Tracking business by indication is critical for evaluating market performance and making accurate resource allocations
Patrick Angelastro
Advertisement
Articles by Patrick Angelastro
Pharmaceutical Executive
When rebate strategies are coupled with sales force and DTC spending, it results in "margin-negative" business-that is, sales that bring in less than the marginal cost of selling, promoting, and manufacturing the drug.
Advertisement
Latest Updated Articles
No Margin for ErrorSeptember 1st 2005
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
2
FDA Approves Wegovy HD Injectable Under Accelerated Approval
3
What Are the ‘Last Mile Issues’ Impacting Pharma?
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5